The comprehensive portfolio extends from pharmaceutical vials to complex drug delivery systems such as RTF® (ready-to-fill) syringe systems, insulin pens and inhalers for safe medication dosage and application.
Gerresheimer will also be talking about the benefits of glass and plastic as materials for pharmaceutical packaging products at the conference, a much appreciated information platform for experts from around the world. The “Plastic versus Glass: High Performance Vials” presentation by Dr. Wolfgang Dirk, Product Manager Plastic Parenteral Vials, is scheduled for Wednesday, February 23.
Visitors to the Gerresheimer exhibition stand can obtain information and advice about tubular glass, moulded glass, plastic packaging and medical plastic systems products from the experts. “We will be exhibiting a very comprehensive and innovative range of products at Pharmapack Paris. By regularly sharing experience and knowledge with our partners, we intend to continue developing high quality and sophisticated pharmaceutical primary packaging products for our customers,” said Claudia Petersen, Director Business Development at Gerresheimer Bünde GmbH, the Gerresheimer Group’s syringe competence center.
“The Medical Plastic Systems division delivers a fully comprehensive service extending from the initial design sketches through tool making, automation technology and production to packaging and international logistics,” added Karin Strasser, Marketing Director Medical Plastic Systems.
The diverse pharmaceutical packaging products and customer-specific medical plastic systems will be on display directly next to the Pharmapack entrance on Stand 133. They include the new multilayer plastic vials for parenteral medications, ClearJectTM COP syringes, RTF® syringe systems, the Duma® twist-off closures with US seal and various inhalers, pens and diagnostic systems.
Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma and healthcare industry. Our comprehensive portfolio of products extends from pharmaceutical vials to complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application. Together with our partners, we develop solutions which set standards and have role model status in their respective market sectors.
Our Group realizes at 44 locations in Europe, North and South America and Asia revenues of around one billion Euros and has 9,500 employees. We use first-rate technologies, convincing innovations and targeted investments to systematically consolidate our strong market position.